Health Robotics Holds Annual Scientific Advisory Board Meeting with Leading Global Hospital Pharmacists

BOZEN, Sud-Tirol, Italy, May 17, 2011 - Health Robotics today announced the company's 2011 Annual Scientific
Advisory Board (SAC) Meeting, jointly hosted this week by Campus BioMedico
University Hospital facilities in Rome and Health Robotics' Research &
Development Center in Trieste, Friuli-Venezia Giulia Region, Italy.

"Under the leadership of Fabio Fioravanti, Health Robotics' Chief
Technical Officer, the SAC launches to a great start in 2011. We are all very
grateful to Campus BioMedico University Hospital for hosting their SAC
colleagues this year, and showcasing Health Robotics' products to the rest of
SAC Board Members from University of Chicago, Ochsner Clinic, USC University
Hospital, Sutter Health, Grifols, and Bolzano General Hospital, and finally
to all of the participants in this week's events. Amongst the SAC highlights
include the scientific review of gravimetric control processes, USP797 and
cGMP regulations, negative and positive pressure chambers for robotic IV
compounding, accuracy of QS doses, prevention of cross-contamination, and
finally "hands-on" and peer-reviewed sessions on CytoCare, i.v.STATION,
i.v.SOFT, i.v.STATION ONCO, and TPNstation," stated Gaspar DeViedma, Health
Robotics' Executive Vice President.

The role of the Scientific Advisory Board is to assist Health Robotics'
Research and Development efforts to complete its revolutionary I.V. Room of
the Future concept: a "Patient-Aware, All-Digital" construct depicting a
common visual and operational framework that elevates the overall
understanding of the patients' I.V. Medication needs - its clinical,
logistics, quality, costs, and procedural structures; the real-time tracking
of I.V. Medications across the care continuum; the optimization of robotics
and software automation tools to bridge the gap between rising patient
volume/acuity and scarce pharmacy personnel resources; and finally the
procedural discipline through visible steps and/or check-points that ensure
that critical steps are taken, quality procedures are followed, and audit
trails are generated as a by-product of the IV Admixture process.

About Health Robotics:

Founded in 2006, Health Robotics is the undisputed global leading
supplier of life-critical intravenous medication robots, providing over 180
hospital installations in 6 continents with robotics-based technology and
software automation solutions deployed utilizing virtual high-availability
technology. Its world-leading solutions CytoCare(R) and i.v.STATION(R) ONCO
[hazardous IVs], i.v.STATION(R) [non-hazardous IVs], i.v.SOFT(R) [workflow
engine for manual compounding], MEDarchiver(R) [life-critical clinical
information system], and TPNstation(TM) [totally-automated parenteral
nutrition] have and will greatly contribute to ease hospitals' growing
pressures to improve patient safety, increase throughput and contain costs.
Through the effective and efficient production of sterile, accurate,
tamper-evident and ready-to-administer IVs, Health Robotics' solutions help
hospitals eliminate life-threatening drug and diluent exchange errors,
decrease other medical mistakes and sterility risks, work more efficiently,
reduce waste and controlled substances' diversion, and diminish the gap
between rising patient volume/acuity and scarce medical, nursing, and
pharmacy staff. For more information, please visit:
www.health-robotics.com

    For additional information, please contact:

    Claudia Flaim, Marketing Coordinator
    flaim@health-robotics.com
    Phone: +39-0471-200-372

.